增强CT扫描对结直肠癌肝转移化疗所致肝窦阻塞综合征的诊断效能:影像与病理对照研究
回顾性分析67例结直肠癌肝转移新辅助化疗后肝切除患者的术前CT,与病理金标准对照。29例(43%)存在肝窦阻塞综合征,其中低级别22例(33%)、高级别7例(10%)。多因素分析显示三叶草征(OR 1.87,95%CI 1.18-2.95,p=0.0081)、脾体积增加≥30%(OR 1.29,95%CI 1.01-1.64,p=0.04)及不均匀分布呈外周性(OR 1.53,95%CI 1.21-1.94,p<0.001)为独立预测因子,ROC曲线下面积0.804,观察者间一致性中等(Kappa=0.546)。
要点
- 肝窦阻塞综合征在结直肠癌肝转移新辅助化疗后患者中占43%,其中高级别占10%。
- 三叶草征、脾体积增加≥30%及不均匀分布呈外周性是肝窦阻塞综合征的独立CT预测因子。
- CT诊断肝窦阻塞综合征的ROC曲线下面积为0.804,观察者间一致性中等(Kappa=0.546)。
核心结论
- CT扫描可检测结直肠癌肝转移化疗患者中提示肝窦阻塞综合征的征象;将临床和生物学信息整合到CT数据中,可能有助于建立化疗所致肝窦阻塞综合征的阳性诊断和严重程度评分。
研究设计与样本
- 回顾性分析2011至2016年67例接受新辅助化疗后肝切除的结直肠癌肝转移患者的术前CT扫描;由三名病理学家对切片共同复核确立肝窦阻塞综合征的阳性诊断和严重程度,术前CT由两名放射科医生独立判读,参照文献综述和操作者经验定义提示征象。
关键影像表现/征象
- 肝脏不均匀(p<0.001)、水坑样或微结节样表现(p<0.001)、不均匀呈外周性分布(p=0.085)、三叶草征(p=0.02)、脾肿大(p=0.0026)、脾体积增加≥30%(p=0.04)或脾长径增加≥15%(p=0.04)以及观察者的主观印象(P<0.001)与肝窦阻塞综合征诊断显著相关。
- 多因素分析中,三叶草征(OR 1.87,95%CI 1.18-2.95,p=0.0081)、脾体积增加≥30%(OR 1.29,95%CI 1.01-1.64,p=0.04)及不均匀呈外周性分布(OR 1.53,95%CI 1.21-1.94,p<0.001)为独立的肝窦阻塞综合征预测因子。
诊断标准与关键数值
- 肝窦阻塞综合征诊断的ROC曲线下面积为0.804。
- 两名放射科医生对肝窦阻塞综合征诊断的观察者间一致性为中等(Kappa=0.546)。
- 29例(43%)患者存在肝窦阻塞综合征,其中低级别22例(33%)、高级别7例(10%)。
临床应用与阅片要点
- 在结直肠癌肝转移新辅助化疗患者的术前CT阅片时,应关注三叶草征、脾体积增加≥30%及不均匀呈外周性分布等提示肝窦阻塞综合征的征象。
- CT诊断肝窦阻塞综合征的观察者间一致性为中等(Kappa=0.546),阅片时需注意判读差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Sinusoidal obstruction syndrome (SOS) is a likely side effect of colorectal liver metastases (CRLM) chemotherapy. This study aimed to assess computed tomography scan (CT-scan) performance for SOS diagnosis for patients receiving neoadjuvant chemotherapy (NC) prior to CRLM surgery, comparing obtained results with pathological gold standard.
METHODS: Preoperative CT-scans of 67 patients who had received a NC prior to liver resection for CRLM from 2011 to 2016 were retrospectively analysed. Positive diagnosis and severity of SOS were established after consensual review of the slides by three pathologists. Preoperative CT-scans were separately interpreted by two radiologists and evocative signs of SOS were sought, defined according to a literature review and operators experience. In order to identify SOS predictors, univariate analysis and multivariate logistic regression were used to study CT-scan signs and pathological results correlation.
RESULTS: Twenty-nine patient (43%) had an SOS, 22 (33%) were low-grade and 7 (10%) were high-grade. All patient had received a median of 6 cures (3-27) containing Oxaliplatin for 53 (79%) of them. In univariate analysis, hepatic heterogeneity (p<0.001), puddle-like or micronodular appearance (p<0.001), peripheral distribution of heterogeneity (p=0.085), clover-like sign (p=0.02), splenomegaly (p=0.0026), spleen volume increase ≥30% (p=0.04) or splenic length increase ≥15% (p=0.04), as well as the subjective impression of the observer (P<0.001) were significantly associated with SOS diagnosis. In multivariate analysis, clover-like sign (OR 1.87, 95% CI 1.18-2.95, p=0.0081), increase in spleen volume ≥30% (OR 1.29, 95% CI 1.01-1.64, p=0.04), and the peripheral distribution of heterogeneity (OR 1.53, 95% CI 1.21-1.94, p<0.001) were independent SOS predictors. The area under the ROC curve was 0.804. The inter-observer agreement for SOS diagnosis was moderate (Kappa=0.546).
CONCLUSION: CT-scan can detect suggestive signs of SOS in patients receiving chemotherapy for CRLM. By integrating clinical and biological information into CT-scan data, it may be fruitful to create a positive diagnostic and severity score for chemotherapy-induced SOS.
引用
- Cayet S, Pasco J, Dujardin F, et al. Diagnostic performance of contrast-enhanced CT-scan in sinusoidal obstruction syndrome induced by chemotherapy of colorectal liver metastases: Radio-pathological correlation. Eur J Radiol. 2017. PMID: 28712693. doi:10.1016/j.ejrad.2017.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。